Engaging, strategic, customer-centric communication is important in any industry, and no industry has been unaffected by the changing world of digital communication.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh